EGFR and cancer: A variety of modalities for blocking EGFR expression and/or function in cancer cells including anti-EGFR monoclonal antibodies (mAbs) and EGFR tyrosine kinase inhibitors (TKI) have been proven effective, particularly when used in combination [4], [5], [7].